TP53 and neoplasm: By contrast, p53 is deleted in skin SCC presenting EMT, and inhibition of ATR does not affect the resistance of EMT tumour cells to chemotherapy, suggesting that RHOJ regulates other mechanisms to mediate resistance to therapy in EMT tumour cells.